Earnings & Investor News · Week of Nov 2, 2026
Deals, impairments and cost cuts mark Q3 earnings week
Third-quarter reports dominated by acquisitions, impairments and cost programs, with Pfizer and Hecla raising guidance and Delek posting a refining surge.
Deals shaped much of the week's third-quarter reporting. Keurig Dr Pepper reported its first full quarter including JDE Peet's, Charter Communications its first results including Cox, and Brink's said it now expects to close its NCR Atleos acquisition in early January 2027. Utz Brands skipped guidance and a conference call ahead of its take-private by Intersnack Group, which it expects to close in the fourth quarter of 2026.
Non-cash charges and cost cutting were a second thread. Charter booked a $6.3 billion franchise impairment and is targeting $2 billion in annualized run-rate operating expense savings, while TELUS took an $800 million goodwill impairment tied to TELUS Health and announced an efficiency program targeting about $900 million in annualized cash savings exiting 2028. On the upside, Pfizer raised its full-year revenue and Adjusted diluted EPS guidance, Hecla reported record free cash flow and raised the low end of its silver production guidance, and Delek reported net income of $1,133.8 million as benchmark crack spreads rose.
Hecla Mining Co/De/
Hecla Reports Third Quarter 2026 Results
Hecla reported third-quarter 2026 revenue of $395 million, income from continuing operations of $150 million, or $0.22 per share, and record free cash flow of $151 million, and raised the low end of 2026 silver production guidance to 15.3 million ounces. The company says it will cut Keno Hill mill throughput to about 300 tons per day in the fourth quarter, with further suppression expected from January 2027, while it pursues permit amendments.
Pfizer Inc
Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance
Pfizer reported third-quarter 2026 revenues of $16.6 billion and Adjusted diluted EPS of $0.87, and raised full-year revenue guidance to $62.0 to $64.0 billion and Adjusted diluted EPS guidance to $2.95 to $3.05. The company says Paxlovid revenues fell 63% operationally while Eliquis rose 25%, and the quarter included a $650 million charge tied to an agreement with Innovent Biologics.
Keurig Dr Pepper Inc.
Keurig Dr Pepper Reports Q3 Results and Reaffirms Guidance for 2026
Keurig Dr Pepper reported third-quarter net sales up 70.6% to $7.34 billion, driven largely by JDE Peet's, with Adjusted diluted EPS up 22.2% to $0.66, and reaffirmed 2026 net sales guidance of $25.9-$26.4 billion. The company says it is working toward remaining milestones for its planned separation into two companies, and its guidance now reflects revised expectations for U.S. Coffee.
Brinks Co
BRINKS CO
Brink's reported third-quarter revenue of $1,375 million, up 3%, with GAAP EPS down 59% to $0.35 and non-GAAP EPS up 18% to $2.46, and said it now expects to close its NCR Atleos acquisition in early January 2027. Excluded costs included $45.7 million for the acquisition and transformation initiatives and $26.6 million of incident-related losses, including a September 2026 precious metals robbery and a warehouse flood.
Charter Communications, Inc.
Charter Announces Third Quarter 2026 Results and Launches New Operating Model
Charter reported an actual net loss attributable to shareholders of $2.4 billion, driven by a $6.3 billion franchise impairment, in its first results including Cox, with pro forma revenue down 1.5% to $16.5 billion. The company launched a new operating model targeting $2 billion in annualized run-rate operating expense savings over 18 months, on top of more than $1 billion in anticipated Cox Transactions synergies.
Delek US Holdings, Inc.
Delek US Holdings Reports Third Quarter 2026 Results
Delek reported third-quarter net income attributable to Delek of $1,133.8 million, or $18.22 per diluted share, against $178.0 million a year earlier, as benchmark crack spreads rose an average of 191.2%. EPA small refinery exemptions reduced Cost of materials and other by $334.7 million, and the Board approved a $0.300 per share quarterly dividend payable November 18, 2026.
TELUS Corporation
TELUS Reports Third Quarter 2026 Results, Demonstrates Continued Discipline in Core Telecom; Advances Transformation Strategy
TELUS reported a third-quarter net loss of $660 million, or $0.42 per share, driven by an $800 million non-cash goodwill impairment related to TELUS Health, with Adjusted EBITDA down 5 per cent to $1.8 billion. The company announced an efficiency program targeting about $900 million in annualized cash savings exiting 2028 and says it is prioritizing the monetization of TELUS Health and TELUS Agriculture & Consumer Goods to reduce debt.
Utz Brands, Inc.
Utz Brands Reports Third Quarter 2026 Results
Utz Brands reported third-quarter Net Sales down 2.3% to $369.2 million and a Net Loss of $32.1 million, citing inflation and a modestly weaker consumer, with Adjusted Gross Profit Margin down 530bps to 27.2%. The company is not providing 2026 guidance or holding a call because of its pending take-private by Intersnack Group, which it expects to close in the fourth quarter of 2026.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Business News Talks reporting.